Amwell® Announces Results for Third Quarter 2025
Rhea-AI Summary
Amwell (NYSE: AMWL) announced financial results for the third quarter ended September 30, 2025. The company said its full third quarter earnings report is available at investors.amwell.com.
Amwell will host a conference call to discuss results on November 4, 2025 at 5:00 p.m. ET; the call is accessible via live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay will be available for approximately 90 days at investors.amwell.com.
Positive
- None.
Negative
- None.
News Market Reaction 6 Alerts
On the day this news was published, AMWL declined 0.79%, reflecting a mild negative market reaction. Argus tracked a trough of -4.2% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $606K from the company's valuation, bringing the market cap to $76M at that time.
Data tracked by StockTitan Argus on the day of publication.
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third quarter ended September 30. The company’s third quarter earnings report may be viewed at investors.amwell.com.
Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay will be available for approximately 90 days at investors.amwell.com.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Contacts
Media:
press@amwell.com
Investors:
Asher Dewhurst
amwell@icrhealthcare.com
FAQ
When will Amwell (AMWL) discuss its Q3 2025 results?
Where can I find Amwell's (AMWL) Q3 2025 earnings report?
How can investors access the live webcast for Amwell's (AMWL) Q3 2025 call?
How long will the Amwell (AMWL) webcast replay for Q3 2025 be available?
What period does Amwell's Q3 2025 earnings cover?
Will Amwell (AMWL) provide financial details during the November 4, 2025 call?
